All Reports Events Blogs Videos
Showing 9 results
  • Tech Launch Perspective
    Dec. 30, 2025

    Cisco’s edge computing infrastructure strategy for AI reflects growing enterprise demand for scalable, secure, and real-time AI deployment at the edge. This report analyzes Cisco’s announcements at the Cisco Partner Summit 2025, emphasizing the company’s Unified…
  • Voice of the Customer
    June 26, 2025

    With rapid digitization expanding the attack surface, the rise in sophisticated and state-sponsored cyber threats, and intensifying regulatory scrutiny on breach monitoring and reporting, demand for comprehensive Cyber Threat Detection and Response (CTDR) solutions continues to…
  • Provider Compendium
    Sep. 22, 2021

    Life Sciences (LS) Operations – Service Provider Compendium provides accurate, comprehensive, and fact-based snapshots of 31 service providers, including their scale of operations, technology solutions, and delivery locations, along with Everest Group’s PEAK Matrix&® service provider…
  • PEAK Matrix®
    June 28, 2021

    The life sciences industry has been severely impacted by the COVID-19 pandemic, with hundreds of clinical trials halted and most ongoing trials disrupted in one way or the other. In the wake of this disruption, enterprises…
  • Provider Compendium
    April 30, 2021

    The Pharmacovigilance - Complaint Management Operations - Service Provider Compendium – provides accurate, comprehensive, and fact-based snapshots of 22 pharmacovigilance and complaint management service providers. It presents providers’ scale of operations, technology solutions, and delivery locations,…
  • PEAK Matrix®
    March 19, 2021

    Traditionally considered to be a cost-function by life sciences enterprises, the pharmacovigilance and device-vigilance / complaint management market is finally getting its long-due attention from all industry sections – including regulatory agencies, drug safety teams, and…
  • Provider Compendium
    Oct. 09, 2020

    Rising costs of drug development, coupled with increasing regulatory pressures, have driven life sciences organizations to reimagine the way clinical trials are conducted – the focus is increasingly shifting toward failing fast and failing cheap. However,…
  • PEAK Matrix®
    Sep. 24, 2020

    The rising costs of drug development, coupled with increasing regulatory pressures, has driven life sciences organizations to reimagine the way clinical trials are conducted – the focus is increasingly shifting toward failing fast and failing cheap.…
  • PEAK Matrix®
    May 31, 2019

    Digital technologies have the potential to streamline and accelerate each stage of the clinical trials process – from matching eligible patients to studies, to data collection and monitoring adherence. However, the overall life sciences industry has…